Print page content Print
Increase text size Decrease text size
Text Size

QUEST® and QUEST® PLUS Gel are:

SINGLE DOSE TREATMENTS
QUEST® and QUEST® PLUS Gel are the only Food and Drug Administration (FDA)-approved dewormers on the market that treat and control encysted small strongyles, bots and roundworms in a single dose. QUEST PLUS offers the same effectiveness as QUEST, but also treats and controls tapeworms, an important annual treatment in late fall.

PROVEN EFFECTIVE
In a recent study, horses treated with moxidectin, the active ingredient in QUEST and QUEST PLUS, showed a 99.9% reduction in fecal egg counts compared with only a 42% reduction in horses treated with five double-dose tubes of fenbendazole, marketed as Panacur® Powerpac or Safe-Guard® Power-Dose®.1,*

LONG LASTING
QUEST and QUEST PLUS are the only FDA-approved products to suppress the production of small strongyle eggs, and a recent study showed egg suppression persisted for 90 days.1 This is important, as small strongyles are the No. 1 parasite of concern in adult horses.2

CONFIRMED SAFE
QUEST and QUEST PLUS are proven safe for use in a variety of horses. QUEST and QUEST PLUS are the only products approved to treat encysted small strongyles in breeding mares and stallions.

In 2015, more than 1 million doses of QUEST and QUEST PLUS were sold in the United States, and more than 9 million doses have been sold in the U.S. since 2004.3

Do not use QUEST Gel or QUEST PLUS Gel in foals less than 6 months of age or in sick, debilitated and underweight horses. Do not use in other animal species, as severe adverse reactions, including fatalities in dogs, may result.


1 Mason ME, Voris ND, Ortis HA, et al. Comparison of a single dose of moxidectin and a five-day course of fenbendazole to reduce and suppress cyathostomin fecal egg counts in a herd of embryo transfer-recipient mares. J Am Vet Med Assoc. 2014;245(8):944-951.*
2 American Association of Equine Practitioners. AAEP Parasite Control Guidelines. Available at: http://www.aaep.org/info/parasite-control-guidelines. Accessed January 29, 2016.
3 QUEST PLUS and QUEST Sales Data. Zoetis. December 2015.
* This study compared QUEST (moxidectin) Gel with Panacur Powerpac (fenbendazole).

QST-00039

CONTACT US

1-888-963-8471

We are Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2020 Zoetis Services LLC. All rights reserved.